Clinical Trial Update: Change of Renal Function and Bone Mineral Density in CHB Patients Switch From TDF to TAF vs. Maintaining TDF [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating changes in renal function and bone mineral density in chronic hepatitis B patients who switch from tenofovir disoproxil fumara…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Vemlidy (tenofovir alafenamide)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Humanity and Health Research Centre | Conditions: Chronic Hepatitis B | Phase 4 | Status: COMPLETED